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BY-NC-ND license (http://creativecomAbstract Background: Mycobacterium tuberculosis (Mtb) persists within immature phago-
somes by preventing their maturation into phagolysosomes. Although the early secretory anti-
genic target 6 (ESAT-6) system 1 (ESX-1) secretion-associated protein B (EspB) of Mtb is strongly
linked to immunogenicity and virulence of this organism, its mechanism of action remains
largely unclear. This study aimed to investigate EspB effects on autophagy in murine ANA-1
macrophage cells.
Methods: EspB gene was amplified by polymerase chain reaction from Mtb H37Rv genomic DNA
to express recombinant EspB protein. Levels of autophagic markers, including Microtubule-
associated protein 1 light chain 3 beta (LC3B-I and -II), phosphorylated signal transducer and
activator of transcription (STAT)1 and total STAT1 in ANA-1 cells treated with EspB proteins
were assessed by Western blotting. In addition, autophagic vacuoles were detected by fluores-
cence microscopy. Finally, IFN-gR1 expression was evaluated by semiquantitative reverse tran-
scriptase polymerase chain reaction and flow cytometry.
Results: EspB gene was expressed in Escherichia coli cells to yield a soluble N-terminal gluta-
tione S-transferase tag fusion protein used in subsequent experiments. Preincubation with
EspB significantly suppressed autophagosome formation and LC3B expression induced by inter-
feron (IFN)-g stimulation, in a dose-dependent manner. These results were confirmed by the
reduced incorporation of monodansylcadaverine, a marker for the acidic compartment of
autolysosomes, after treatment with EspB. Interestingly, we found that IFN-g receptor 1 mRNA
and protein levels were decreased in EspB-stimulated ANA-1 cells in comparison with un-
treated cells. Finally, EspB protein also inhibited IFN-g-activated STAT1 phosphorylation,
thereby downmodulating macrophage responsiveness to IFN-g.of Infection and Immunity, School of Basic Medical Sciences, West China Center of Medical Sciences,
ction, Renmin South Road, Chengdu 610041, Sichuan, China.
cn (L. Bao).
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downregulating IFN-g receptor 1 expression. Overall, EspB should be considered a relevant fac-
tor in the pathogenesis of mycobacterial infections in humans.
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Autophagy is a major homeostatic cellular mechanism,
responsible for the removal of damaged organelles and
elimination of intracellular pathogens.1e4 Mycobacterium
tuberculosis (Mtb) is a facultative intracellular pathogen,
characterized by its intracellular survival in host macro-
phages.5 It has been shown that Mtb persists within imma-
ture phagosomes by preventing their maturation into
phagolysosomes.6 However, induction of autophagy by
interferon (IFN)-g can overcome mycobacterial inhibition
of phagosome maturation and is therefore critical for Mtb
eradication from murine and human macrophages.7 Inter-
estingly, Mtb downregulates autophagy, the main feature
enabling persistence of this microorganism in the host
cellular environment.8 However, the mechanisms by which
Mtb reduces autophagy as well as its implications for host
cell viability remain to be elucidated.
Although the early secretory antigenic target 6 (ESAT-6)
system 1 (ESX-1) secretion apparatus is critical to Mtb
virulence,9 its mechanisms of action are not fully under-
stood. ESX-1 secretion-associated protein B (EspB), a 48-
kDa protein encoded by the Rv3881c gene of Mtb H37Rv,
constitutes a novel substrate of the ESX-1 secretion system
and plays an important role in Mtb virulence.10 Indeed,
EspB is required for cytolysis, bacterial spreading, andtein and EspBeGST fusion exp
performed on 12% sodium do
rker; Lanes: 1, E. coli BL21 cont
after induction; 4, bacterial cul
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hione S-transferase.ESAT-6 secretion.11,12 More importantly, EspB is critical to
inhibition of phagosome maturation and EspB deletion re-
sults in acidification of the bacterial phagosome.13 Despite
its implication in hostepathogen interactions during Mtb
infection, the precise role of EspB in innate immune regu-
lation remains to be determined.
In this work, we aimed to investigate further the role of
EspB in host immune responses. We found that the EspB
protein pretreatment significantly suppressed autophago-
some formation and LC3B expression after interferon (IFN)-
g stimulation in ANA-1 macrophage cells. In addition, EspB
treatment resulted in downmodulation of IFN-g receptor 1
(R1) expression on macrophage cell surface, and inhibition
of IFN-g-induced autophagy by suppressing IFN-gR1 signal
transducer and activator of transcription (STAT)1 phos-
phorylation. These data suggest that EspB inhibits auto-
phagosome formation in murine macrophages, effects due,
at least in part, to downmodulation of IFN-gR1 expression.
Methods
Cloning, expression, and purification of EspB
protein
The gene encoding EspB was amplified by polymerase chain
reaction (PCR) from Mtb H37Rv genomic DNA (AL123456.3),ressed in Escherichia coli. (A) Sodium dodecyl sulfate poly-
decyl sulfate polyacrylamide gel and stained with Coomassie
rol; 2, BL21 containing plasmid pGEX-4T-1 prior to induction; 3,
ture before induction of the fusion protein in BL21; 5, bacterial
fusion protein purified on a GST column; 7, purified GST fusion
ST tag monoclonal antibodies. E. coli harboring pGEX-4T-1-EspB
hours at 30C. Lanes 1, 26-kDa GST fusion partner protein; and
retory antigenic target 6 (ESAT-6) system 1 (ESX-1) secretion-
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ATG ACGCAGTCGCAGACCGT-30; and EspB reverse P2, 50-
GCCTCGAGTCACTTCGACTCCTTACTGT-30 (EcoRI and XhoI
sites, respectively, are underlined). Restriction endonu-
cleases and Taq DNA polymerase were purchased from MBI
Fermentas (Shanghai, China). The PCR product was cloned
into the expression vector pGEX-4T-1 (Zihan, Tianjing,
China). After the clone integrity was confirmed by DNA
sequencing, the recombinant vector was transformed into
Escherichia coli BL21 (DE3) for expression. The EspB protein
was purified using Ni sepharose high-performance purifica-
tion columns (GE Healthcare, USA) according to standard
procedures. The purified fusion protein underwent cleav-
age with thrombin to remove the glutathione S-transferase
(GST) tag, which was separated using a GST-affinity column
(GE Healthcare, USA). After this purification step, the EspB
protein was subjected to an endotoxin-removing gel
(Detoxi-Gel; Pierce, Rockford, IL, USA) according to man-
ufacturer’s instructions, for removal of E. coliFigure 2. EspB suppressed IFN)-g-induced autophagy. (A) ANA-1 c
6 hours, followed by 16 hours challenge with IFN-g (200 U/mL). Ce
anti-b-actin antibodies. (B) LC3B-II band intensities were normalize
compared with that obtained for cells without IFN-g treatment. Th
pendent experiments. (C) ANA-1 cells were fixed and stained with m
treatment (UT); (2) pretreatment with EspB (40 mg/mL); (3) treatmen
EspB (40 mg/mL) and treatment with IFN-g (200 U/mL) for 16 hours. *
system 1 (ESX-1) secretion-associated protein B; IFN Z interferon;lipopolysaccharide contamination. The purified endotoxin-
free EspB was lyophilized and stored at 70C until use.
The protein concentration was assessed using the BCA
Protein Assay Kit (Pierce).
Cell culture
ANA-1 cells (Fanke, Shanghai, China) were cultured in RPMI
1640 (Invitrogen, Carlsbad, CA, USA) supplemented with
10% fetal calf serum, 100 U/mL penicillin, and 100 mg/mL
streptomycin at 37C in a humidified environment con-
taining 5% CO2.
Cell lysis and Western blot analysis
Approximately 107 cells were collected, washed twice with
ice-cold phosphate buffered saline (PBS), lysed in cell lysis
RIPA Buffer (SigmaeAldrich, St. Louis, MO, USA) for 20ells were treated with EspB at the indicated concentrations for
ll lysates were assessed by Western blotting using anti-LC3B or
d to b-actin. The ratio of LC3B-II to b-actin in each sample was
e data represent mean  standard deviation from three inde-
onodansylcadaverine (original magnification, 200) after (1) no
t with IFN-g (200 U/mL) for 16 hours; and (4) pretreatment with
p < 0.05. EspBZ The early secretory antigenic target 6 (ESAT-6)
LC3B Z Microtubule-associated protein 1 light chain 3 beta.
Figure 3. Effects of EspB protein on expression of IFN-gR1
mRNA in ANA-1cells. ANA-1 cells were treated with 40 mg/mL
EspB and total RNA was extracted at the indicated time points.
Untreated ANA-1 cells were used as controls. Expression of
mRNA was assayed by semiquantitative RT-PCR. Percent inhi-
bition was calculated by densitometry analysis and normali-
zation to b-actin mRNA levels. (A) Representative gel image of
semiquantitative RT-PCR depicting the variation of IFN-gR1
mRNA expression at various time points. (B) Histogram showing
the normalized data for IFN-gR1 (IFN-gR1/b-actin) in treated
and untreated ANA-1 cells. Data represent mean  standard
deviation from three independent experiments with similar
results. *p < 0.05. EspBZ The early secretory antigenic target
6 (ESAT-6) system 1 (ESX-1) secretion-associated protein B; IFN-
gR1 Z interferon-g receptor 1; RT-PCR Z reverse transcrip-
tase polymerase chain reaction.
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Cell lysates were centrifuged at 12,000 g for 20 minutes at
4C and the resulting supernatants were collected. Protein
concentrations were determined as described above. Equal
amounts of protein were separated by 15% or 8% sodium
dodecyl sulfate polyacrylamide gel electrophoresis and
transferred onto polyvinylidene difluoride membranes
(Millipore, Billerica, MA, USA). After blocking in Tris-
buffered salineeTween-20 containing 5% nonfat milk,
membranes were incubated overnight at 4C with primary
antibodies against Microtubule-associated protein 1 light
chain 3 beta (LC3B-I and -II) (Cell Signaling Technology,
Danvers, MA, USA), phosphorylated STAT1 (Tyr701), and
total STAT1 (Signalway Antibody, College Park, MD, USA).
Afterwards, membranes were washed and incubated with
secondary antibodies conjugated with horseradish peroxi-
dase (ZSGB-Bio, Beijing, China) for 1 hour at room tem-
perature. The blots were probed using the ImageQuant ECL
system (Sigma) and quantified by laser densitometry.
Fluorescence microscopy analysis
For detection of autophagic vacuoles, cells were seeded on
sterile coverslips and treated with 40 mg/mL EspB protein for
6 hours, followed by 16 hours challenge with 200 U/mLmouse
recombinant IFN-g (Peprotech, Rocky Hill, NJ, USA). Then,
cells were incubated with 50 mM monodansylcadaverine
(SigmaeAldrich) in PBS at 37C for 1 hour. Finally, coverslips
were washed four times with PBS, immediately sealed, and
images were acquired using a fluorescence microscope
manufactured by Carl Zeiss (Jena, Germany).
Semiquantitative reverse transcriptase PCR for
assessment of IFN-gR1 expression
RNA was isolated from ANA-1 cells using the total RNA
extraction kit (Bio Flux, USA). Total RNA (1 mg) was added to a
50-mL reaction mixture of the Quant One-Step RT-PCR kit
(Tiangen Biotech, Beijing, China). Primers used for reverse
transcriptase PCR were: IFN-gR1 forward, 50-GTGTATTC
GGGTTCCTGGACTGATT-30; IFN-gR1 reverse, 50-CGAATGTG-
TAACAGGTGCTCCCGTC-30; b-actin forward, 50-GAGACCTT-
CAACACCCCAGC-30; and b-actin reverse, 50-ATGTCACGCAC
GATTTCCC -30. The PCR products were analyzed using the
Quantity One analysis software (BioRad, Hercules, CA, USA).
Flow cytometry assays
For flow-cytometry analysis, ANA-1 cells (treated and un-
treated) were incubated with biotin anti-mouse CD119 (IFN-
gR1 chain) antibodies (Biolegend, San Diego, CA, USA) fol-
lowed by streptavidinephycoerythrin (Biolegend). After-
wards, the stained cells were washed and resuspended in
PBS at 106 cells/300 mL. Finally, the samples were analyzed
by flow cytometry on a FACSCalibur (BectoneDickinson,
Franklin Lakes, NJ, USA).
Statistical analysis
Data are presented as mean  standard deviation of trip-
licate observations. Student t test was used to analyze thedata. Values of p < 0.05 were considered statistically
significant.
Results and discussion
Purification of recombinant EspB expressed in E.
coli
The EspB gene was expressed in E. coli cells harboring
pGEX-4T-1, to yield a soluble N-terminal GST-tag fusion
protein which was purified by affinity chromatography.
Western blot data clearly revealed high expression levels of
a 74-kDa fusion protein, which was equivalent to the pre-
dicted molecular weight (Fig. 1). The endotoxin content of
the purified EspB protein devoid of the GST tag was <0.05
endotoxin units per microgram of protein.
EspB suppresses IFN-g-induced autophagy
We measured LC3B protein expression in ANA-1 cells
treated with EspB prior to IFN-g treatment and found that
EspB protein suppresses autophagy 863EspB alone did not affect the expression level of LC3B
(Fig. 2A, lanes 1 and 2; Fig. 2B, lanes 1 and 2). With EspB
pretreatment for 6 hours followed by IFN-g treatment, the
IFN-g-induced enhancement of LC3B protein expression was
reduced in a dose-dependent manner (Fig. 2A, lanes 3e6)
as quantified by laser densitometry (Fig. 2B).
To confirm that autophagosome formation was inhibited
by EspB, we assessed the incorporation of mono-
dansylcadaverine, a marker for the acidic compartment of
autolysosomes.14 As shown in Fig. 2C, EspB alone did not
affect ANA-1 cell autophagic vacuoles. Upon treatment
with 200 U/mL IFN-g, an increased production of auto-
phagic vacuoles in ANA-1 cells was observed (Fig. 2C). By
contrast, 40 mg/mL EspB pretreatment markedly reduced
the IFN-g-induced accumulation of vacuoles (Fig. 2C).
Taken together, these results demonstrate that EspB
inhibited IFN-g-induced autophagosome formation in ANA-1
cells (Fig. 2).
EspB protein decreases IFN-gR1expression in
macrophage cells
To assess whether the expression of IFN-gR1 was modulated
by EspB, ANA-1 cells were stimulated for 6 hours with EspBFigure 4. Effects of EspB on IFN-gR1 expression in ANA-1cells. AN
6 hours. After treatment, the cells were washed and stained for IFN
histogram plots showing the surface expression of IFN-gR1 in untre
the cumulative mean fluorescent intensity of IFN-gR1 surface exp
mean  standard deviation from three independent experiments
antigenic target 6 (ESAT-6) system 1 (ESX-1) secretion-associated pprotein. Semiquantitative reverse transcriptase PCR
showed decreased mRNA levels of IFN-gR1 in EspB-
stimulated ANA-1 cells in comparison with untreated cells
(Fig. 3). The IFN-gR1 proteins on the cell surface were
labeled with fluorescent antibody. Flow cytometry showed
that the mean fluorescence intensity on the cell surface
was significantly lower in EspB-stimulated cells compared
with untreated cells (p < 0.05; Fig. 4), indicating decreased
surface IFN-gR1 level.
EspB protein suppresses IFN-g-induced STAT1
phosphorylation
As shown in Fig. 5, western blot analysis of STAT1 and its
phosphorylated form showed that IFN-g treatment signifi-
cantly increased phosphorylation of STAT1 in ANA-1 cells.
This enhancement of STAT1 phosphorylation by IFN-g was
suppressed by EspB protein.
Autophagy is a process that controls the quality and
quantity of intracellular biomass in eukaryotic cells by
targeting autodigestion of cytoplasmic components that
range in complexity and size from individual proteins to
whole organelles.15 During autophagy, parts of the cyto-
plasm and intracellular organelles are enwrapped inA-1 cells were stimulated with the EspB protein (40 mg/mL) for
-gR1. Untreated cells were used as controls. (A) Representative
ated controls and EspB-treated ANA-1 cells. (B) Quantitation of
ression in untreated and treated ANA-1 cells. Data represent
with similar results. *p < 0.05. EspB Z The early secretory
rotein B; IFN-gR1 Z interferon-g receptor 1.
864 D. Huang, L. Baodouble-membrane vesicles called autophagosomes, which
are ultimately delivered to lysosomes for bulk degrada-
tion.16 Autophagy is a crucial weapon for the host cell in
fighting against bacterial and viral invasion. However, it is
now evident that highly evolved intracellular pathogens
including Mtb have specialized anti-autophagy adaptations
that allow them to prevent, block, or elude autophagic
elimination.7 Despite extensive studies, the specific bac-
terial factors that undermine host autophagy remain largely
unknown. A limited number of Mtb components, including
lipoprotein LpqH17 and Eis protein,18 have been suggested
to contribute to this process.
Mtb is known to evade successfully the host immune
system by various cellular mechanisms. The ability of Mtb
to block macrophage responses to IFN-g is an important
trait developed by the bacteria to evade cell-mediated
immunity. Mtb-infected human macrophages are desensi-
tized to activation by IFN-g.19e21 The antimicrobial prop-
erties of IFN-g result in part from its ability to stimulate
autophagy in host cells.8,22,23 We hypothesized that the
Mtb attenuation of cytokine responsiveness of host cells
also alters the IFN-g-dependent activation of autophagy
pathways. Indeed, the present data demonstrated that
EspB inhibits IFN-g-induced autophagy; a possible mech-
anism by which the bacteria evade the host immune
system.Figure 5. EspB protein suppressed IFN-g-induced STAT1
phosphorylation. (A) ANA-1 cells were treated with EspB
(40 mg/mL) for 6 hours, followed by IFN-g (200 U/mL) incuba-
tion for 1 hour. Cell lysates were examined by Western blotting
using anti-pSTAT1 or anti-total STAT1 antibodies. (B) The in-
tensity values obtained for pSTAT1 were normalized to total
STAT1. The ratio of pSTAT1/STAT1 in each sample was
compared to that of untreated cells. Data represent
mean  standard deviation from three independent experi-
ments. *p < 0.05. EspB Z The early secretory antigenic target
6 (ESAT-6) system 1 (ESX-1) secretion-associated protein B; IFN-
g Z interferon-g; pSTAT Z phosphorylated signal transducer
and activator of transcription.The autophagy process involves formation and matura-
tion of autophagosomes, and is mediated by the expression
of microtubule-associated protein 1A/1B-light chain 3
(LC3), a mammalian homolog of yeast autophagy related
gene 8 (Atg8). It has been shown that LC3B cleavage into
LC3B-I and subsequently LC3B-II plays a critical role in
autophagosome formation.24 This is observed in Western
blot assays where two bands are usually detected by anti-
LC3B antibodies: LC3B-I (18 kDa) and LC3B-II (16 kDa).
Interestingly, it has been shown that LC3B-II amounts
correlate well with autophagosome numbers, allowing the
use of LC3 conversion in monitoring autophagy.25
The data presented here showed that treatment of ANA-
1 cells with EspB alone did not alter LC3B-II production.
However, reduced LC3B-II protein expression was observed
in EspB-pretreated murine ANA-1 cells triggered by subse-
quent treatment with IFN-g. These findings suggest that
EspB suppresses the IFN-g-induced autophagy, an effect
that possibly correlates with IFN-g signaling.
Classical IFN-g-induced cellular effects involve activa-
tion of the Janus kinase STAT1-regulated signaling events.
The binding of IFN-g to its cognate receptor induces the
assembly of an active receptor complex and subsequent
transphosphorylation of the receptor-associated Janus
tyrosine kinases Jak1 and Jak2. This is followed by
recruitment of the cytosolic STAT1 protein to the active
complex. Following translocation into the nucleus, the
dimerized STAT1 induces transcription of cellular genes to
mediate the initiation of various antimicrobial processes,
including cytokine expression and autophagy.26e29 Li et al30
confirmed the crucial role of STAT1 activation in IFN-g-
induced autophagy.
The EspB protein downregulates IFN-gR1 and inhibits
IFN-g-activated STAT1 phosphorylation, thereby down-
modulating macrophage responsiveness to IFN-g. The pre-
sent characterization of the mycobacterial effector EspB as
a modulator of autophagy presents a previously unknown
paradigm in the understanding of hostepathogen in-
teractions in mycobacterial infection. However, because
EspB is only one of many molecules that mediate Mtb im-
mune modulation, the autophagy-dysregulating effect of
EspB could be masked by an entire set of mycobacterial
components in the context of the whole bacillus. For
instance, Mtb is known to modulate macrophage function
by affecting the host pathway that is dependent on nitric
oxide synthase 2, which generates toxic reactive nitrogen
intermediates.31 Future studies using EspB mutant bacteria
as well as in vivo experiments are needed to assess further
the effect of EspB.
In conclusion, we demonstrated here that the EspB
protein inhibits IFN-g-induced autophagy in mouse macro-
phages. This inhibitory effect is due in part to the down-
regulation of IFN-gR1 and results in the inhibition of IFN-g-
induced STAT1 phosphorylation. The ability of purified EspB
to inhibit macrophage function is a relevant component in
the pathogenesis of such chronic mycobacterial infections
in humans.Conflicts of interest
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